MAIA Biotechnology Files 8-K with Key Agreements and Sales
Ticker: MAIA · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1878313
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
MAIA Bio filed an 8-K on 6/24 reporting material agreements, equity sales, and financials.
AI Summary
On June 24, 2025, MAIA Biotechnology, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, reported unregistered sales of equity securities, and included financial statements and exhibits. The filing was made on June 26, 2025.
Why It Matters
This 8-K filing indicates significant corporate actions by MAIA Biotechnology, including new agreements and equity sales, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Numbers
- 001-41455 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-1495913 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- June 26, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Principal executive offices address
FAQ
What is the nature of the material definitive agreement entered into by MAIA Biotechnology, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before June 24, 2025.
What type of equity securities were sold unregistered?
The filing mentions unregistered sales of equity securities but does not provide specific details on the type or amount of securities sold.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 24, 2025.
What are the principal executive offices of MAIA Biotechnology, Inc.?
The principal executive offices of MAIA Biotechnology, Inc. are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the SEC file number for MAIA Biotechnology, Inc.?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding MAIA Biotechnology, Inc. (MAIA).